Hepatitis D virus and liver disease
Research activity includes therapies for chronic hepatitis D virus infection, with interest in viral RNA reduction and treatment options for persistent HDV infection.
- Chronic hepatitis D virus infection
- HDV RNA
- Antiviral therapy
The sponsor’s work in this area is centered on hepatology and the management of viral liver disease.
Complement-mediated diseases
Clinical research also covers complement system-related conditions, reflecting interest in inflammatory and immune-driven disorders linked to complement dysregulation.
- Complement-mediated diseases
- Complement inhibition
- Immune-mediated disease
This area aligns with therapeutic development in immunology and inflammatory disease.
Lipid disorders
The sponsor is active in mixed dyslipidemia, with research focused on abnormal lipid metabolism and treatment of elevated or imbalanced blood lipids.
- Mixed dyslipidemia
- Lipid lowering
- Cardiometabolic risk
These studies place emphasis on cardiovascular prevention and metabolic health.
Cardiovascular disease
Research includes stable coronary artery disease, with attention to chronic atherosclerotic cardiovascular disease and ongoing antiplatelet-treated populations.
- Stable coronary artery disease
- Atherosclerosis
- Cardiovascular therapeutics
The sponsor’s cardiovascular focus spans ischemic heart disease and related long-term management.
